Leonardo Lorente1, María M Martín2, Juan M Borreguero-León3, Jordi Solé-Violán4, José Ferreres5, Lorenzo Labarta6, César Díaz7, Alejandro Jiménez8, José A Páramo9. 1. Intensive Care Unit, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain. Electronic address: lorentemartin@msn.com. 2. Intensive Care Unit. Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain. 3. Laboratory Deparment, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain. 4. Intensive Care Unit, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain. 5. Intensive Care Unit, Hospital Clínico Universitario de Valencia, Valencia, Spain. 6. Intensive Care Unit, Hospital San Jorge de Huesca, Huesca, Spain. 7. Intensive Care Unit, Hospital Insular, Las Palmas de Gran Canaria, Spain. 8. Research Unit, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain. 9. Atherosclerosis Research Laboratory, CIMA, University of Navarra, Pamplona, Spain.
Abstract
BACKGROUND: Higher plasma plasminogen activator inhibitor-1 (PAI-1) levels have been reported in septic patients. However, some questions remain unanswered, such as whether there is an association between plasma PAI-1 levels and sepsis severity and mortality, and inflammation state during the first week. METHODS: Multicenter, observational and prospective study carried out in six Spanish Intensive Care Units of 260 patients with severe sepsis. Circulating levels of PAI-1 and tumour necrosis factor (TNF)-α were measured at day 1, 4 and 8. End-point was 30-day mortality. RESULTS: Nonsurviving septic patients (n=89) presented higher PAI-1 levels than surviving (n=171) at day 1 (58.4 (33.3-83.8) vs 36.5 (21.1-62.5) ng/mL; p<0.001), 4 (34.0 (14.7-53.3) vs 16.2 (10.2-27.4) ng/mL; p<0.001) and 8 (30.6 (16.2-47.8) vs 18.9 (10.4-29.5) ng/mL; p=0.004). We found a positive correlation of PAI-1 levels with SOFA, lactic acid, aPTT, INR and TNF-α, and negative with platelet count at day 1, 4 and 8. Logistic regression analyses showed that PAI-1 levels at day 1 (p<0.001), 4 (p<0.001) and 8 (p=0.001) were associated with 30-day mortality. On ROC curve analysis to predict 30- day survival, the area under the curve of PAI-1 levels at day 1, 4 and 8 were 0.65 (95% CI=0.58-0.72; p<0.001), 0.69 (95% CI=0.60-0.78; p<0.001) and 0.65 (95% CI=0.54-0.75; p=0.005) respectively. CONCLUSIONS: The most interesting findings of our study, to our knowledge the largest series reporting PAI-1 levels during follow-up in septic patients, were that plasma PAI-1 levels during the first week were associated with inflammation, severity and mortality.
BACKGROUND: Higher plasma plasminogen activator inhibitor-1 (PAI-1) levels have been reported in septic patients. However, some questions remain unanswered, such as whether there is an association between plasma PAI-1 levels and sepsis severity and mortality, and inflammation state during the first week. METHODS: Multicenter, observational and prospective study carried out in six Spanish Intensive Care Units of 260 patients with severe sepsis. Circulating levels of PAI-1 and tumour necrosis factor (TNF)-α were measured at day 1, 4 and 8. End-point was 30-day mortality. RESULTS: Nonsurviving septic patients (n=89) presented higher PAI-1 levels than surviving (n=171) at day 1 (58.4 (33.3-83.8) vs 36.5 (21.1-62.5) ng/mL; p<0.001), 4 (34.0 (14.7-53.3) vs 16.2 (10.2-27.4) ng/mL; p<0.001) and 8 (30.6 (16.2-47.8) vs 18.9 (10.4-29.5) ng/mL; p=0.004). We found a positive correlation of PAI-1 levels with SOFA, lactic acid, aPTT, INR and TNF-α, and negative with platelet count at day 1, 4 and 8. Logistic regression analyses showed that PAI-1 levels at day 1 (p<0.001), 4 (p<0.001) and 8 (p=0.001) were associated with 30-day mortality. On ROC curve analysis to predict 30- day survival, the area under the curve of PAI-1 levels at day 1, 4 and 8 were 0.65 (95% CI=0.58-0.72; p<0.001), 0.69 (95% CI=0.60-0.78; p<0.001) and 0.65 (95% CI=0.54-0.75; p=0.005) respectively. CONCLUSIONS: The most interesting findings of our study, to our knowledge the largest series reporting PAI-1 levels during follow-up in septic patients, were that plasma PAI-1 levels during the first week were associated with inflammation, severity and mortality.
Authors: Brittany A Zwischenberger; Beverly K Balasuriya; Dwight D Harris; Nisha Nataraj; Allison M Owen; Maria E C Bruno; Sujata Mukherjee; Victor Ortiz-Soriano; William O'Connor; Chenlu Ke; Arnold J Stromberg; Phillip K Chang; Javier A Neyra; Hiroshi Saito; Marlene E Starr Journal: Shock Date: 2021-05-01 Impact factor: 3.454
Authors: Leonardo Lorente; María M Martín; Juan M Borreguero-León; Ysamar Barrios; Jordi Solé-Violán; José Ferreres; Lorenzo Labarta; César Díaz; Alejandro Jiménez Journal: PLoS One Date: 2015-06-11 Impact factor: 3.240
Authors: Maria E C Bruno; Sujata Mukherjee; Arnold J Stromberg; Hiroshi Saito; Marlene E Starr Journal: J Cell Physiol Date: 2021-08-09 Impact factor: 6.384
Authors: Timothy L Tipoe; William K K Wu; Lilianna Chung; Mengqi Gong; Mei Dong; Tong Liu; Leonardo Roever; Jeffery Ho; Martin C S Wong; Matthew T V Chan; Gary Tse; Justin C Y Wu; Sunny H Wong Journal: Front Immunol Date: 2018-06-18 Impact factor: 7.561